Summary Safety Review - Codeine-containing products - Further Assessing the Risk of Serious Breathing Problems in Children and Adolescents

In 2013 and 2015, Health Canada carried out safety reviews on codeine-containing products as they relate to the risk of potentially life-threatening breathing problems. At the time, it was recommended that codeine-containing products no longer be used in children under 12 years of age. New safety reviews were carried out to further assess the risk of serious breathing problems in children and adolescents treated with codeine to decide if more should be done to manage this risk in this age group.

Data and Resources

Additional Info

Field	Value
Last Updated	April 17, 2026, 21:57 (UTC)
Created	April 17, 2026, 21:57 (UTC)
criticality_level	[]
geographic_scope	[]
open_canada_collection	publication
open_canada_date_published	2020-12-07 00:00:00
open_canada_keywords	{"fr": ["Examen sommaire de l'innocuité", "produits contenant de la codéine", "évaluation", "problèmes respiratoires graves", "enfants et adolescents traités à la codéine"], "en": ["Summary Safety Review", "Codeine-containing products", "assessing", "serious breathing problems", "Children and Adolescents", "treated with codeine"]}
open_canada_subject	["health_and_safety"]
sensitivity_level	unrestricted
title_fr	Résumé de l'examen de l'innocuité - Produits contenant de la codéine - Évaluation approfondie du risque de problèmes respiratoires graves chez les enfants et les adolescents
update_frequency	as_needed